NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-CA-20-048 from the NIH Guide for Grants and Contracts
Notice NOT-DC-20-003 from the NIH Guide for Grants and Contracts
Notice NOT-DK-20-012 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-20-163 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within the awarding IC identified in the competitive revision NOSI. Applications for Revisions will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), in accordance with NIH peer review policy and procedures, using the stated review criteria. Only applications submitted in response to a NOSI published by an NIH Institute or Center will be allowed to apply to this FOA.
Funding Opportunity PAR-20-164 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote research to understand the underlying mechanisms of sleep deficiencies among health disparity populations and how sleep deficiencies may lead to disparities in health outcomes.
Notice NOT-AG-20-022 from the NIH Guide for Grants and Contracts
Notice NOT-HG-20-031 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-21-009 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to seek applications for the Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers (IDDRCs). This FOA invites applications for research center grants designed to advance the diagnosis, prevention, treatment, and amelioration of intellectual and developmental disabilities (IDD). This FOA seeks applications from institutions that meet the qualifications for a multi-disciplinary program of IDD research that will include: 1) Cores that facilitate interdisciplinary and translational research in IDD and its dissemination, and that support IDD-related projects funded by other sources; and 2) at least one specific research project related to one of several focus themes identified as an area of research need in IDD. Funds for the majority of outside research projects using these core facilities come from independent sources including Federal, State, and private organizations.
Funding Opportunity PA-20-162 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible, domestic institutions to develop and/or enhance research training opportunities for predoctoral students interested in careers in biomedical, behavioral, or clinical research. Many NIH Institutes and Centers (ICs) use this NRSA program exclusively to support intensive, short-term research training experiences for health professional students (medical students, veterinary students, and/or students in other health-professional programs) during the summer. This program is also intended to encourage training of graduate students in the physical or quantitative sciences to pursue research careers by short-term exposure to, and involvement in, the health-related sciences. The training should be of sufficient depth to enable the trainees, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of biomedical research. This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.
Funding Opportunity PAR-20-161 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to provide investigators with access to a consultative resource for planning activities and concept development for single or multi-site investigator initiated clinical trials that address gaps in pediatric drug development and that align with priorities identified in the Best Pharmaceuticals for Children Act (BPCA) Program. The FOA will support the development of clinical trials concepts of future well-designed clinical trials that require non-traditional designs in pediatric therapeutics with the opportunity to expand novelty and/or innovation. Investigators will have access to the expertise in pediatric drug development trial designs by utilizing the consultative services provided by the Pediatric Trials Network (PTN) and the BPCA Data Coordinating Center.
Notice NOT-TR-20-015 from the NIH Guide for Grants and Contracts
Notice NOT-DK-20-016 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-21-017 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for institutional research career development (K12) programs from applicant organizations that propose to support a program of mentored institutional career development programs for junior faculty investigators who have recently completed postgraduate clinical training in a subspecialty area of Pediatrics and are committed to launching an independent research career. The program provides supervised biomedical research training to assist the transition of junior faculty investigators into productive and independent physician-scientists.
Funding Opportunity RFA-NS-20-029 from the NIH Guide for Grants and Contracts. set to be a reissue of: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-029.html
Notice NOT-HD-20-011 from the NIH Guide for Grants and Contracts
Notice NOT-MD-20-018 from the NIH Guide for Grants and Contracts
Notice NOT-MH-20-035 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-158 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2.
Funding Opportunity PAR-20-156 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) enables data-driven drug repositioning and combination therapy for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) by developing computational methods and data resources and/or integrating computational approaches with proof-of-concept efficacy studies in cell-based models, animal models, and/or humans.
Notice NOT-NS-20-026 from the NIH Guide for Grants and Contracts